Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin alpha-C1 is a neural cadherin-like cell adhesion protein encoded by the human PCDHAC1 gene, part of the protocadherin alpha gene cluster on chromosome 5. This protein is an integral plasma membrane molecule believed to play a critical role in establishing and maintaining specific neuronal cell-cell connections in the brain, likely contributing to the organization of neural circuits. Structurally, it contains multiple extracellular cadherin ectodomains responsible for cell adhesion, and its function is at least partly calcium-dependent. Although primarily studied for its role in neural development, alterations in PCDHAC1 have been associated with autism spectrum disorder. There is currently no evidence that it is a target for marketed drugs or recognized as a direct therapeutic target[1][3][5][6][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin alpha-C1 (PCDHAC1).